USANA Q4 net loss $1.8M; core customers down 15%; FY2026 guidance flat to 8% growth

USANA HEALTH SCIENCES INC

2025-FY EPS reported $0.58 revenue$925,257,000

Q4 net loss $1.8M vs profit $4.5M YoY; adjusted diluted EPS $0.60 (down 6% from $0.64).
FY2025 net sales $925M (+8% YoY); core nutritional net sales down 8%, active customers down 15% to 387k.
Recorded $7M goodwill impairment and $6.5M cost realignment charge in Q4, boosting effective tax rate to 72.4%.
FY2026 guidance: consolidated net sales $925M-$1.0B (flat to 8% growth); adjusted diluted EPS $1.95-$2.29.
Hiya net sales grew 17% in FY2025; Rise Wellness net sales tripled; non-core now 16% of consolidated sales.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.